Passwort anzeigen
Passwort vergessen?
Werden Sie kostenlos Mitglied
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Dynamische Kurse 


ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MERCK & CO., INC.
17.09.MERCK : le CHMP approuve le Keytruda pour des cancers du sein
17.09.MERCK : Receives Positive Opinion for Keytruda, Chemotherapy Combination From Eu..
17.09.MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combi..
17.09.Merck Gets CHMP Backing of Keytruda in Triple-Negative Breast Cancer
17.09.MERCK : EquiTrace wins Best Start-Up Award & new Best Vet Tech Award at the Inno..
16.09.SILVERBACK THERAPEUTICS : Reports Early Data From Phase 1/1b Study of SBT6050 in..
16.09.HOOKIPA PHARMA : announces clinical collaboration with Merck & Co., Inc., Kenilw..
16.09.BIOXCEL THERAPEUTICS : Says Therapeutics Study Shows Anti-Tumor Activity of Pros..
16.09.BIOCORP and MERCK Sign a Partnership in the Field of Human Growth Hormone
15.09.HOOKIPA PHARMA : Merck Collaborate on Head, Neck Cancer Combo Therapy Developmen..
15.09.HOOKIPA Pharma Inc. Announces Clinical Collaboration with Merck & Co., Inc., ..
15.09.Hookipa Working With Merck in Advanced Head and Neck Cancers
14.09.IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 ..
13.09.Merck sees potential U.S. authorization for COVID-19 antiviral before year-en..
13.09.MERCK & C : mpany CEO Expects Clinical Data on Covid Vaccine in H2 2021, Possibl..
13.09.MERCK : Cooley Continues Life Sciences Partnering Growth On East Coast
09.09.Codexis, Inc. and Merck Amend and Extend License and Supply Agreement for Enz..
09.09.U.S. government to tackle Medicare drug payments to try to cut costs
09.09.PDS BIOTECHNOLOGY : Completes Recruitment in Safety Cohort of Phase 2 Study of H..
09.09.MERCK : les prévisions de croissance de Life Science revues à la hausse
09.09.PLANÈTE BOURSE : La revue de presse du jeudi 9 septembre 2021
08.09.MERCK : To Present New Data From Its Broad Oncology Portfolio and Pipeline at ES..
08.09.Merck To Present New Data From Its Broad Oncology Portfolio and Pipeline at E..
07.09.Illumina, Merck to Collaborate Over Diagnostic Tests For Cancer Mutations
07.09.MERCK : recul du titre, un broker dégrade son opinion
07.09.MERCK : Morgan Stanley dégrade sa recommandation
07.09.MERCK : nouvelle approbation du Keytruda en Chine
07.09.Today on Wall Street: Back to business
07.09.ANALYST RECOMMENDATIONS : Amgen, Banner, Merck, Oracle, Phoenix...
07.09.MERCK : Says Keytruda is Now Approved for Additional Indication of Carcinoma in ..
07.09.MERCK : to Present at the Morgan Stanley 19th Annual Healthcare Conference
07.09.MERCK : KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemothe..
07.09.Merck’s Keytruda (Pembrolizumab) Approves in China in Combination with Chemot..
01.09.GLOBAL MARKETS LIVE : Getlink, Intuit, CrowdStrike, Xiaomi, Merck...
01.09.IMMUTEP : Completes Patient Enrollment in Stage 2 of Part B of NSCLC Study; Shar..
01.09.MERCK : démarrage d'un essai dans la Covid-19
01.09.MERCK : Ridgeback Biotherapeutics Launch Phase 3 Trial of Potential COVID-19 Ant..
01.09.MERCK : and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOV..
01.09.Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MO..
01.09.Merck, Ridgeback Launch Phase 3 Trial of Covid-19 Prophylactic
01.09.IMMUTEP : Completes Recruitment, Dosing in Phase 2 Trial of Non-Small Cell Lung ..
01.09.BÖRSE MADRID : El apoyo, cuando nos retienen
01.09.BÖRSE PARIS : Soutien, quand tu nous tiens
01.09.EN DIRECT DES MARCHES : Carrefour, Engie, Pernod Ricard, BioMérieux, Medincell, ..
31.08.MERCK : Secures FDA Full Approval for Updated Indication for Keytruda to Treat B..
31.08.MERCK : FDA Approves Updated Indication for Merck's KEYTRUDA® (pembrolizumab) fo..
31.08.Merck Announces Label Update for Keytruda, Merck’s Anti-PD-1 Therapy, for Its..
27.08.OSE IMMUNOTHERAPEUTICS : Enrolls First Patient in Phase 2 Study of Ovarian Cance..
26.08.MERCK : deux nouvelles indications pour Keytruda au Japon
26.08.MERCK : Keytruda Wins Two New Japanese Approvals
26.08.MERCK : KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan
26.08.Merck’s Keytruda (Pembrolizumab) Receives Two New Approvals in Japan
25.08.MERCK : résultats positifs pour Vaxneuvance chez les bébés
25.08.MERCK : Pneumococcal Vaccine Meets Safety Endpoints in Trial Reviewing Use in In..
25.08.Warren Buffett's latest shopping spree
25.08.MERCK : Announces VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) ..
25.08.Merck & Co., Inc. Announces Topline Results from the Pivotal PNEU-PED (V114-0..
25.08.Merck's Vaxneuvance Hits Key Endpoints in Infant Study
24.08.Les dernières emplettes de Warren Buffett
23.08.MERCK : Leslie A. Brun Resigns from Merck Board of Directors
23.08.MERCK : WELIREGTM (belzutifan), FDA Approved, Available at Biologics by McKesson
23.08.MERCK : un administrateur indépendant quitte le conseil
20.08.MERCK : Leslie A. Brun Resigns from Merck Board of Directors (Form 8-K)
20.08.MERCK & CO., INC. : Financial Statements and Exhibits (form 8-K)
20.08.Merck & Co., Inc. Announces Resignation of Leslie A. Brun as Board of Directo..
20.08.MERCK : Leslie A. Brun Resigns from Merck Board of Directors
19.08.ADAGENE : Joins Forces With Merck for Study of Cancer Treatment Candidate ADG106..
19.08.Adagene Announces the Third Clinical Trial Collaboration with Merck to Advanc..
18.08.WEREWOLF THERAPEUTICS : Collaborates With Merck on Solid Tumor Program
18.08.Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on it..
18.08.Werewolf to Study WTX-124 With Merck's Keytruda in Solid Tumors
17.08.STREET COLOR : Berkshire Hathaway Takes New Position in Organon, Dumps Biogen, A..
16.08.MERCK : FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha (HIF-2?) Inhibitor..
14.08.MERCK : FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha (HIF-2α) Inh..
14.08.MERCK : Canada Initiates Rolling Submission to Health Canada for Molnupiravir, a..
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für MERCK & CO., INC.
Anstehende Branchentermine